Evidence map›Paper›PMID 42082453›Full record

ArticleCell death & disease2026

STUB1-induced polyubiquitination of SIK3 in alveolar type 2 epithelial cells alleviates severity and outcomes of acute lung injury.

Feng Tian, Nianlin Xie, Daixing Zhong, Yunfeng Ni, Binghua Zhang, Xiaohua Liang, Jun Ma, Xiaokang Gong, Zhuochen Sun, Jie Zhao and 2 more

Abstract read
In one paragraph

Article in Cell death & disease, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Feng Tian *Department of Thoracic Surgery, Tangdu Hospital, Air Force Medical University (formerly known as Fourth Military Medical University), Xi'an, PR China. doctianfg@hotmail.com.ORCID http://orcid.org/0000-0002-6822-046X
Nianlin Xie *Department of Thoracic Surgery, Tangdu Hospital, Air Force Medical University (formerly known as Fourth Military Medical University), Xi'an, PR China.
Daixing Zhong *Department of Thoracic Surgery, Tangdu Hospital, Air Force Medical University (formerly known as Fourth Military Medical University), Xi'an, PR China.
Yunfeng Ni *Department of Thoracic Surgery, Tangdu Hospital, Air Force Medical University (formerly known as Fourth Military Medical University), Xi'an, PR China.
Binghua ZhangDepartment of Pulmonary and Critical Care Medicine, Air Force 986 Hospital, Air Force Medical University (formerly known as Fourth Military Medical University), Xi'an, PR China.
Xiaohua LiangDepartment of Thoracic Surgery, Tangdu Hospital, Air Force Medical University (formerly known as Fourth Military Medical University), Xi'an, PR China.
Jun MaDepartment of Thoracic Surgery, Tangdu Hospital, Air Force Medical University (formerly known as Fourth Military Medical University), Xi'an, PR China.
Xiaokang GongDepartment of Thoracic Surgery, Tangdu Hospital, Air Force Medical University (formerly known as Fourth Military Medical University), Xi'an, PR China.
Zhuochen SunDepartment of Thoracic Surgery, Air Force 986 Hospital, Air Force Medical University (formerly known as Fourth Military Medical University), Xi'an, PR China.
Jie ZhaoDepartment of Human Anatomy, Histology and Embryology, Basic Medical Science Academy, Air Force Medical University (formerly known as Fourth Military Medical University), Xi'an, PR China.
Tao JiangDepartment of Thoracic Surgery, Tangdu Hospital, Air Force Medical University (formerly known as Fourth Military Medical University), Xi'an, PR China.ORCID http://orcid.org/0000-0002-5848-1922
Wei LiDepartment of Human Anatomy, Histology and Embryology, Basic Medical Science Academy, Air Force Medical University (formerly known as Fourth Military Medical University), Xi'an, PR China. liweipepeyato@163.com.ORCID http://orcid.org/0000-0003-2487-3773

Funding

National Natural Science Foundation of China (National Science Foundation of China) 31971070National Natural Science Foundation of China (National Science Foundation of China) 81770068
6 · The paper itself

Abstract

Disruption in alveolar type 2 epithelial cells (AT2s) homeostasis by oxidative stress plays an essential role in the pathogenesis of acute lung injury (ALI). However, significant discrepancies remain in understanding the mechanisms for AT2 as a main target for reactive oxygen species (ROS). Herein, we show that STUB1, an E3 ligase involved in protein homeostasis, was dominantly expressed in AT2s. Mild levels of ROS potentiated Nrf2-mediated transactivation of the STUB1 gene via activation of the ERK signaling, whereas high levels of ROS compromised STUB1 expression by dampening STUB1 protein half-life. Ablation of Stub1 in AT2s caused failure in conferring K63-mediated nonproteolytic polyubiquitination of SIK3 (salt-inducible kinase 3), which in turn abrogated CRTC2 (CREB-regulated transcription co-activator 2) substrate binding for SIK3 and thereby triggered CREB signaling-mediated proinflammatory phenotypes. Consequently, disruption in STUB1/SIK3 signaling aggravated lung edema, augmented inflammatory infiltrate, and increased AT2 apoptosis in vivo. Mice lacking STUB1 also demonstrated increased susceptibility to ischemia-reperfusion and overventilation-induced lung injury. These findings unambiguously uncover STUB1 as a critical post-translational regulator of ALI severity and outcomes.

Indexed as

Acute Lung InjuryAlveolar Epithelial CellsProtein Serine-Threonine KinasesUbiquitin-Protein LigasesAnimalsApoptosisHumansMiceMice, Inbred C57BLReactive Oxygen SpeciesSignal TransductionUbiquitinationProtein Serine-Threonine KinasesReactive Oxygen SpeciesStub1 protein, mouseUbiquitin-Protein Ligases

Identifiers

PMID42082453
PMCPMC13284247

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.